Fig. 4From: Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipientsKaplan-Meier estimate of allograft survival; blue line: all-cause allograft loss, grey line: death-censored allograft lossBack to article page